Journal of Clinical Technology and Theory

Open access

Print ISSN: 3049-5458

Online ISSN: 3049-5466

Submission:
JCTT@ewapublishing.org Guide for authors

About JCTT

Journal of Clinical Technology and Theory (JCTT) is an open access, peer-reviewed academic journal published by EWA Publishing. JCTT is published bimonthly. JCTT focuses on the frontiers of the clinical technology and theory, aims to build an open and inclusive platform for academic exchanges. JCTT welcomes all the researchers, scholars and workers, who dedicate in the clinical medicine field, to share their new findings and ideas about clinical technology and theory. JCTT hopes to let these excellent works more disseminated and help the clinical area's development.

For more details of the JCTT scope, please refer to the Aim & Scope page. For more information about the journal, please refer to the FAQ page or contact info@ewapublishing.org.

Aims & scope of JCTT are:
·Basic Medicine
·Clinical Medicine
·Preventive Medicine
·Pharmaceutical Science
·Medical Technology
·Nursing

View full aims & scope

Editors View full editorial board

Maher Nawaf
University of Birmingham
Birmingham, UK
Editor-in-Chief
mnawaf@captechu.edu
Alvina Haseeb
University of Agriculture, Faisalabad
Faisalabad, Pakistan
Editorial Board
Tooba Mahboob
UCSI University
Kuala Lumpur, Malaysia
Editorial Board
Rujuta Naik
University of Nottingham
Nottingham, UK
Editorial Board

Latest articles View all articles

Research Article
Published on 13 January 2026 DOI: 10.54254/3049-5458/2026.31261
Shuhang Xu, Liu Liu

Hashimoto's Thyroiditis (HT), as the primary cause of hypothyroidism worldwide, has shown an increasing prevalence. Although Western medicine can regulate thyroid function, its effect on reducing autoantibodies is limited. Based on the holistic concept and syndrome differentiation and treatment, Traditional Chinese Medicine (TCM) has demonstrated unique advantages in regulating immunity, improving symptoms, and delaying disease progression. By sorting out the etiology, pathogenesis, main treatment methods, and efficacy of HT, this paper aims to explore the progress of TCM in the treatment of HT and provide ideas and methods for clinical practice. However, there is a lack of high-quality clinical evidence for TCM treatment of HT. In the future, high-quality clinical trials are needed to confirm the efficacy, so as to promote new breakthroughs in TCM treatment of HT.

Show more
View pdf
Xu,S.;Liu,L. (2026). Advances in traditional Chinese medicine treatment for Hashimoto's thyroiditis. Journal of Clinical Technology and Theory,4(1),78-84.
Export citation
Research Article
Published on 6 January 2026 DOI: 10.54254/3049-5458/2026.31192
Jie Shi

Gout is a metabolic disease caused by the deposition of monosodium urate, marked by severe pain and inflammation. Globally, its incidence rate is on the rise, and the incidence population is getting younger, which has become a key public health problem. The treatment methods of Western medicine can quickly exert anti-inflammatory and analgesic effects, but cannot cure the disease. Traditional Chinese medicine has become a potential treatment for gout. From the perspective of traditional Chinese medicine's principle of syndrome differentiation and treatment, Chinese medicine can regulate the organs of the body, improve metabolic disorders at the root, reduce the production of uric acid, and promote its excretion from the body. Chuanxiong, as a traditional Chinese medicine, has a synergistic effect of various active ingredients such as ligustrazine and ferulic acid, which can alleviate pain, reduce inflammation, reduce urea, improve microcirculation, and have antioxidant effects. It is used to treat gout. In the future, the mechanism of action of Ligusticum chuanxiong in treating gout can be exploited through the development of combination drugs, and a new treatment strategy can be created, providing reference for further research on the pathogenesis of gout and the development of new drugs.

Show more
View pdf
Shi,J. (2026). Analysis of the mechanism and efficacy of Chuanxiong intreating gout. Journal of Clinical Technology and Theory,4(1),72-77.
Export citation
Research Article
Published on 30 December 2025 DOI: 10.54254/3049-5458/2025.31067
Shuhang Xu, Fengyun Cheng

Thyroid nodules are common diseases of the endocrine system, which belong to the category of "goiter" in Traditional Chinese Medicine (TCM). The TCM treatment of benign thyroid nodules takes syndrome differentiation and treatment as the core, forming a multi-therapy system including oral administration of Chinese herbal medicine and external treatment, with continuous deepening of relevant research and application. This paper systematically sorts out the clinical application status of various characteristic TCM therapies in the treatment of benign thyroid nodules, and looks forward to the prospects around the optimization of clinical diagnosis and treatment and the explanation of mechanisms of action, aiming to provide ideas for the TCM treatment of benign thyroid nodules.

Show more
View pdf
Xu,S.;Cheng,F. (2025). Research progress of traditional Chinese medicine in the treatment of benign thyroid nodules. Journal of Clinical Technology and Theory,4(1),61-71.
Export citation
Research Article
Published on 25 December 2025 DOI: 10.54254/3049-5458/2025.30941
Kaisheng Ma

Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most lethal human malignancies with poor survival outcome. It is characterized by late diagnosis, rapid growth and limited therapeutic choices. Increasing evidence has suggested that gene expression may undergo extensive changes during the process of normal cells to malignant transformation which may play a critical role in the initiation and progression of human PDAC. In this study, we applied single-cell RNA sequencing (scRNA-seq) technology to comprehensively compared the Peripheral Blood Mononuclear Cells (PBMCs) and tissue samples from pancreatic ductal adenocarcinoma patients and normal individuals. We characterized transcriptional heterogeneity and identified differentially expressed genes as well as the changes of immune microenvironment between PDAC and normal individuals through integrative bioinformatic analysis. We believe that our results will provide new insights into the cellular and molecular characterization of PDAC and may provide potential implications for future therapeutic approaches and biomarker discoveries.

Show more
View pdf
Ma,K. (2025). Single-cell sequencing analysis of the pancreatic cancer samples. Journal of Clinical Technology and Theory,4(1),39-60.
Export citation

Volumes View all volumes

Volume 4January 2026

Find articles

Conference website:

Conference date: 1 January 0001

ISBN: (Print)/(Online)

Editor:

Volume 3December 2025

Find articles

Conference website:

Conference date: 1 January 0001

ISBN: (Print)/(Online)

Editor:

Volume 3May 2025

Find articles

Conference website:

Conference date: 1 January 0001

ISBN: (Print)/(Online)

Editor:

Volume 3August 2025

Find articles

Conference website:

Conference date: 1 January 0001

ISBN: (Print)/(Online)

Editor:

Indexing

The published articles will be submitted to following databases below: